Nahi, H <br/><br/>
Different impact of intermediate and unfavourable cytogenetics at the time of diagnosis on outcome of de novo AML after allo-SCT: a long-term retrospective analysis from a single institution.  [electronic resource] 

 -  Medical oncology (Northwood, London, England)  Dec 2012 
 - 2348-58 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1559-131X 
<br/><br/><label>Standard No.: </label>10.1007/s12032-011-0155-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Child<br/>Child, Preschool<br/>Chromosome Aberrations<br/>Female<br/>Hematopoietic Stem Cell Transplantation<br/>Histone-Lysine N-Methyltransferase<br/>Humans<br/>Infant<br/>Infant, Newborn<br/>Leukemia, Myeloid, Acute--genetics<br/>Male<br/>Middle Aged<br/>Myeloid-Lymphoid Leukemia Protein--genetics<br/>Retrospective Studies<br/>Transplantation, Homologous<br/>Treatment Outcome